Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases (Q36310340)

13 August 2017

1 reference

title

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases (English)

1 reference

13 August 2017

0 references

Marta Ruiz-Ortega

1 reference

13 August 2017

Marta Ruiz-Ortega

1 reference

13 August 2017

Mónica Rupérez

1 reference

13 August 2017

Vanesa Esteban

1 reference

13 August 2017

Juan Rodríguez-Vita

1 reference

13 August 2017

Elsa Sánchez-López

1 reference

13 August 2017

Giselle Carvajal

1 reference

13 August 2017

Jesús Egido

1 reference

13 August 2017

language of work or name

English

0 references

publication date

9 November 2005

1 reference

Nephrology Dialysis Transplantation

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

16-20

1 reference

Proinflammatory actions of angiotensins.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Molecular mechanisms of angiotensin II-induced vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Angiotensin II increases connective tissue growth factor in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

AT1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFI265

21 January 2018

Identifiers

DOI

10.1093/NDT/GFI265

1 reference

13 August 2017

1 reference